首页> 美国卫生研究院文献>other >Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery
【2h】

Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery

机译:可生物降解的基于聚酸酐的纳米药物用于血液到大脑的药物输送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An urgent need to deliver therapeutics across the blood-brain barrier (BBB) underlies a paucity of effective therapies currently available for treatment of degenerative, infectious, traumatic, chemical and metabolic disorders of the nervous system. With an eye towards achieving this goal, an in vitro BBB model was employed to simulate biodegradable polyanhydride nanoparticle-based drug delivery to the brain. Using a combination of confocal microscopy, flow cytometry, and high performance liquid chromatography, we examined the potential of polyanhydride nanoparticles containing the anti-oxidant, mito-apocynin, to be internalized and then transferred from monocytes to human brain microvascular endothelial cells. The efficacy of this nanoparticle-based delivery platform was demonstrated by neuronal protection against oxidative stress. Taken together, this polyanhydride nanoparticle-based delivery system holds promise for enhancing neuroprotection by facilitating drug transport across the BBB.
机译:迫切需要跨血脑屏障(BBB)进行治疗的基础是目前缺乏可用于治疗神经系统退行性,感染性,创伤性,化学和代谢性疾病的有效疗法。为了实现这一目标,我们采用了体外BBB模型来模拟可生物降解的基于聚酸酐纳米颗粒的药物向大脑的输送。使用共聚焦显微镜,流式细胞仪和高效液相色谱仪相结合,我们检查了含有抗氧化剂米托阿波西宁的聚酸酐纳米颗粒被内化然后从单核细胞转移到人脑微血管内皮细胞的潜力。通过基于神经元的抗氧化应激保护证明了这种基于纳米颗粒的递送平台的功效。综上所述,这种基于聚酸酐纳米颗粒的递送系统有望通过促进药物跨BBB的转运来增强神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号